Dr. Claudia Kleinman
January 2023Research at the Lady Davis Institute

Researchers inch closer to better understanding of brain tumours in children

Certain brain cells may be inherently vulnerable to mutations that cause fatal brain tumours in children, says a study co-led by an LDI researcher.

READ MORE →
Artwork by Shelly Alkoby (seated, right) has been donated to the JGH’s Peter Brojde Lung Cancer Centre, where it is going on display. Joining the artist are her mother, Keren Elkoubi (seated), and (standing, from left) Dr. Jason Agulnik, Co Director of the Centre; Nurse Lindsay Hammond, a member of the team that has provided care to Ms. Elkoubi; and Dr. Carmela Pepe, Ms. Elkoubi’s respirologist. (Click on this or any photo to enlarge it.)
December 2022Feature articles

Teen artist hopes her painting will hearten JGH lung cancer patients

Artwork by a teenage artist, inspired by her mother’s battle with lung cancer, is going on display at the JGH.

READ MORE →
Dr. Emily Kay-Rivest
MilestonesSeptember 2022

Dr. Emily Kay-Rivest joins Department of Otolaryngology-Head and Neck Surgery

Dr. Emily Kay-Rivest has joined the JGH Department of Otolaryngology-Head and Neck Surgery as a specialist in ear and skull base surgery.

READ MORE →
Dr. Nathalie Johnson
Research at the Lady Davis InstituteSeptember 2022

Probing the benefits of exercise for patients and survivors of lymphoma

Although exercise is recognized as being good for cancer patients, hematologist Dr. Nathalie Johnson is taking a closer look at how it helps those with lymphoma.

READ MORE →
During a tour of a newly inaugurated JGH lab where clinical trials will be held for a promising cancer treatment, Pierre Fitzgibbon (second from right), Minister of Economy and Innovation, is briefed about the technology by Michel Gareau (right), Founder and President of Starpax Medical, and by Dr. Gerald Batist, Director of the Segal Cancer Centre. (Click this or any photo to enlarge it.)
June 2022News

New JGH lab launched to test potentially revolutionary cancer treatment

A potential breakthrough in cancer treatment, using magnetism to guide medication-carrying bacteria into tumours, will be tested in a new JGH lab.

READ MORE →
Dr. Robin Billick, Chief of Dermatology, in one of his Division’s examination rooms at the JGH. (Click on photo to enlarge it.)
June 2022Milestones

JGH Chief of Dermatology honoured by Israel Cancer Research Fund

Dr. Robin Billick, JGH Chief of Dermatology, is being honoured by the Israel Cancer Research Fund for decades of service in diagnosing cancer and saving lives.

READ MORE →
In the MPN Clinic at the JGH, Karen Gal (left) consults with her hematologist, Dr. Shireen Sirhan. (Click on photo to enlarge it.)
Feature articlesJanuary 2022

Treatment and reassurance at JGH clinic for patients with rare blood cancers

A pace-setting JGH clinic is providing care and support to patients with rare blood cancers, while raising awareness and promoting research.

READ MORE →
At the main entrance of the Hope & Cope Wellness Centre, Program Manager Carly Berlin (left) discusses the Centre’s activities with Volunteer Anne Collette. (Click on this or any photo to enlarge it.)
December 2021Hope & Cope

Hope & Cope’s volunteers rebound from stressful impact of COVID 19

Many Hope & Cope volunteers were troubled by not being allowed to see cancer patients in person during the pandemic, but now those ties are being re-established.

READ MORE →
Dr. Stephen Robbins, Director of the Lady Davis Institute
November 2021Research at the Lady Davis Institute

New Director of Lady Davis Institute aiming to boost LDI’s global prominence and impact

As the new Director of the Lady Davis Institute, Dr. Stephen Robbins hopes to see the LDI gain even more global prominence.

READ MORE →
Dr. Khalil Sultanem, Acting Chief of Radiation Oncology, with one of his Division’s linear accelerators. (Click on this or any photo to enlarge it.)
August 2021News

Major construction to install new cancer-fighting linear accelerator in Radiation Oncology

Construction is under way to install a fourth linear accelerator in Radiation Oncology, making cancer treatment faster and more accurate.

READ MORE →